Venous thromboembolism risk is reportedly decreased in people with blood type B. However, the precise molecular and clinical mechanism underlying the variable sensitivity of ABO blood groups to venous thromboembolism in people with Factor V Leiden remains largely unknown. This evidence concerns the gene F5 and venous thromboembolism.